Sanofi and Regeneron report positive Phase 2b trial results with sarilumab in rheumatoid arthritis
12 July 2011 | By Sanofi
Sanofi and Regeneron Pharmaceuticals, Inc. announced results from Phase 2b trials...
List view / Grid view
12 July 2011 | By Sanofi
Sanofi and Regeneron Pharmaceuticals, Inc. announced results from Phase 2b trials...
11 July 2011 | By Sanofi
Sanofi and Genzyme announced positive top-line results...
11 July 2011 | By Sanofi
Sanofi announced the strategic divestiture of its dermatology business, Dermik, to Valeant Pharmaceuticals International Inc...
7 July 2011 | By Sanofi
Sanofi announced that the company has discontinued the PALLAS Phase IIIb trial...
27 June 2011 | By Sanofi
Sanofi announced the appointment of Peter Guenter, as Senior Vice President, Europe, effective July 15, 2011...
27 June 2011 | By Sanofi
Sanofi announced the winners of the Sanofi Patient Group Bursary scheme - Breakthrough Breast Cancer and the MS Trust...
22 June 2011 | By Sanofi
To better leverage the real-world evidence generated during product development and throughout the product lifecycle...
16 June 2011 | By Sanofi
Sanofi has entered into a research collaboration with Audion Therapeutics to develop potential treatments for hearing loss...
6 June 2011 | By Sanofi
Sanofi announced new data for iniparib (BSI-201)...
6 June 2011 | By Sanofi
Data will be presented at the ESMO World Congress on Gastrointestinal Cancer...